181 related articles for article (PubMed ID: 2985516)
1. Thalidomide therapy. An open trial.
Naafs B; Faber WR
Int J Dermatol; 1985 Mar; 24(2):131-4. PubMed ID: 2985516
[TBL] [Abstract][Full Text] [Related]
2. Successful long-term thalidomide therapy for discoid lupus erythematosus-lichen planus overlap syndrome.
Zhang L; Au S; Aronson IK
Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526013
[TBL] [Abstract][Full Text] [Related]
3. Thalidomide therapy for inflammatory dermatoses.
Grosshans E; Illy G
Int J Dermatol; 1984 Nov; 23(9):598-602. PubMed ID: 6097551
[No Abstract] [Full Text] [Related]
4. A case series of 48 patients treated with thalidomide.
Doherty SD; Hsu S
J Drugs Dermatol; 2008 Aug; 7(8):769-73. PubMed ID: 18720694
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide: dermatological indications, mechanisms of action and side-effects.
Wu JJ; Huang DB; Pang KR; Hsu S; Tyring SK
Br J Dermatol; 2005 Aug; 153(2):254-73. PubMed ID: 16086735
[TBL] [Abstract][Full Text] [Related]
6. Tripterygium in dermatologic therapy.
Xu WY; Zheng JR; Lu XY
Int J Dermatol; 1985 Apr; 24(3):152-7. PubMed ID: 3888878
[No Abstract] [Full Text] [Related]
7. [Thalidomide in dermatology].
Hunziker T; Krebs A
Hautarzt; 1983 Feb; 34(2):66-72. PubMed ID: 6841082
[TBL] [Abstract][Full Text] [Related]
8. Thalidomide and its dermatologic uses.
Moraes M; Russo G
Am J Med Sci; 2001 May; 321(5):321-6. PubMed ID: 11370795
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide: an experience in therapeutic outcome and adverse reactions.
Sharma NL; Sharma VC; Mahajan VK; Shanker V; Ranjan N; Gupta M
J Dermatolog Treat; 2007; 18(6):335-40. PubMed ID: 17852637
[TBL] [Abstract][Full Text] [Related]
10. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.
Tseng S; Pak G; Washenik K; Pomeranz MK; Shupack JL
J Am Acad Dermatol; 1996 Dec; 35(6):969-79. PubMed ID: 8959957
[TBL] [Abstract][Full Text] [Related]
11. [Rediscovery of thalidomide. Successful treatment of discoid lupus erythematosus].
Kuhn A; Hefter H; Ruzicka T; Lehmann P
Hautarzt; 2001 Aug; 52(8):726-33. PubMed ID: 11544946
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticosteroids and oral medicine.
Pedersen A; Klausen B
J Oral Pathol; 1984 Feb; 13(1):1-15. PubMed ID: 6422017
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic changes in thalidomide neuropathy in the treatment of discoid lupus erythematosus].
Ludolph A; Matz DR
EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Dec; 13(4):167-70. PubMed ID: 6295739
[TBL] [Abstract][Full Text] [Related]
14. [Current therapeutic indications of thalidomide and lenalidomide].
Ordi-Ros J; Cosiglio FJ
Med Clin (Barc); 2014 Apr; 142(8):360-4. PubMed ID: 23830554
[TBL] [Abstract][Full Text] [Related]
15. Flurandrenolone (Cordran) tape as occlusive therapy.
Riley K
J S C Med Assoc; 1969 May; 65(5):171-2. PubMed ID: 5254171
[No Abstract] [Full Text] [Related]
16. Long-term thalidomide use in refractory cutaneous lesions of lupus erythematosus: a 65 series of Brazilian patients.
Coelho A; Souto MI; Cardoso CR; Salgado DR; Schmal TR; Waddington Cruz M; de Souza Papi JA
Lupus; 2005; 14(6):434-9. PubMed ID: 16038106
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide experience of a major Australian teaching hospital.
Crouch RB; Foley PA; Ng JC; Baker CS
Australas J Dermatol; 2002 Nov; 43(4):278-84. PubMed ID: 12423435
[TBL] [Abstract][Full Text] [Related]
18. [On the usability of Aristolochia tagala Cham. in dermatology].
Königsbauer H
Z Haut Geschlechtskr; 1968 Feb; 43(4):159-63. PubMed ID: 4233167
[No Abstract] [Full Text] [Related]
19. Innovative uses of thalidomide.
Chen M; Doherty SD; Hsu S
Dermatol Clin; 2010 Jul; 28(3):577-86. PubMed ID: 20510766
[TBL] [Abstract][Full Text] [Related]
20. [Experience in using a zinc-corticotropin suspension in the therapy of certain dermatoses].
Borisenko KK; Glozman VN
Vestn Dermatol Venerol; 1974 May; 48(5):78-80. PubMed ID: 4365447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
